Archive for heart attack

Pro-life hero spends final hours defending babies in front of Planned Parenthood

Posted in Pro-life hero with tags , , , , , , , , on August 25, 2015 by saynsumthn

In one of his last acts on earth, 73-year-old Bob Adis, who was lovingly referred to as “poppy” joined last weekend’s pro-life protest in Livonia, Michigan to expose Planned Parenthood’s gruesome baby parts operation.

Robert-Adis-1440336531

According to pro-life activist Lynn Mills, Bob attended Harvest Bible Church in Westland when the church’s pastor, Dan McGhee posted the demonstration on his church Facebook page.


“I asked Dan to let his church know about the protest and he did add it to his facebook
,” Mills told Saynsumthn.

Harvest Bible Church

Dan and several members of his Detroit Harvest Bible Church family headed to Planned Parenthood in Livonia early Saturday morning.

Livonia Planned Parenthood 362446120822_o

But, sadly, while they stood in the gap for unborn babies, another emergency was unfolding at the clinic.

11888042_1032775180066377_9111965695208742087_n

Bob loved the Lord and Bob loved people,” Pastor McGhee said. “He loved the unborn and wanted to see them have an opportunity at life.

According to a message published by Pastor McGhee on his Facebook page, at about 9:47am, Bob Adis started having chest pains and was removed from the sidewalk in front of Planned Parenthood by ambulance where he defended unborn babies.

By 10:05am Pastor McGhee reported that Bob was not doing well and he was on his way to the hospital to be with Bob and his wife Joan.

Fifteen minutes later, tragically he reported that Bob had passed away.

Pro-lifer Greg Gurta, told Saynsumthn that he met Bob and his wife for the first time that morning at the Planned Parenthood protest.

Police arrive for Bob Adis

Mr. Gurta, who published most of the pictures used in this story, said he recalled seeing police arrive at Planned Parenthood and wondered if they were going to tell them they had to move their cars.

He walked over to the police where he said he could see Bob holding his chest and sitting in a car. According to Gurta, just prior to emergency responders arriving on scene, Pastor McGhee and his church members gathered around Bob to pray before the ambulance took him to the hospital.

Mr. Gurta later posted this message on his Facebook page at the time, “I thought we were in trouble for parking here but found out one of ours had a medical emergency and later passed away. Peace be with you brother Bob — in Livonia, Michigan.”

Bon RObert Adis Planned Parenthood

But, as stated earlier in this story, Bob passed away shortly after he was transported to the hospital.

God chose to call Bob Adis home minutes after standing up against Planned Parenthood in defense of innocent babies. Scripture tells us there is no greater love than to lay your life down for another.

I never met Bob and I attempted to get in touch with those who did so I could write more about his life. Understandably, so close to his funeral, no one was available.

I don’t know anything specific about his life except how he spent his last hours which I will phrase this way,”He loved babies!

But, I did come across this message about Bob’s life which was posted to Facebook:

    Bob Adis, went to be with the Lord today. He spent his last hours serving the Lord defending the lives of the unborn. Please keep his dear wife, Joan in your prayers.

On his tribute wall, someone who knew Bob described him as:

    one of the most caring, kind, patient, thoughtful, peace-loving, and generally wonderful men God has ever created.

His pastor Rev. Dan McGhee told the Detroit Free Press:

    “It’s a remarkable thing to me that Bob, on the very last day God gave him on Earth, he spent it to advocate for life for those who are not given the chance to live their lives. That shows kind of heart he had.”

Please keep Bob’s family in your prayers, especially his wife Joan. Amazingly, the couple celebrated their 55th wedding anniversary a day before he died.

Memorials may be made to Harvest Bible Church, 6420 Newburgh Road, Westland, Michigan 48185.

Tributes, donations, and prayers can be directed to Vermeulen-Sajewski Funeral Home Plymouth.

Robert J. Adis: August 28, 1941 – August 22, 2015

Prolife Robert AdisObituary for Robert J. Adis
Adis, Robert J., suddenly August 22, 2015 age 73 of Canton. Beloved husband of Joan. Loving father of Lynn Ann (Bob) Boertje, Theresa (Ray) Farley, Deborah (Richard) Felton, Thomas (Julie), and Christopher (Shannon). Dear brother of Rhonda Dudley & Richard. Proud “Poppy” of Alexandra, Jessica, Ryan, Jakob, Holland, Dylan, Corey,Lane, Lauren and Ben. Funeral Wednesday 11 AM at Vermeulen-Sajewski Funeral Home, 46401 W. Ann Arbor Road (Between Sheldon and Beck). Visitation Tuesday 3-8 PM. To share a memory, please use the Share a Memory tab on this web page. Memorials may be made to Harvest Bible Church, 6420 Newburgh Road, Westland, Michigan 48185.

Morning-After Abortion Pills Linked to Blood Clots

Posted in Abortion pill, birth control, Birth Control Dangers, Morning After Pill, Plan B with tags , , , , , , , , , on April 1, 2011 by saynsumthn

Morning-After Pills Linked to Blood Clots
Wendy Wright
Just as the Food and Drug Administration (FDA) is on the verge of allowing underage girls to get the morning-after pill with no doctor’s oversight or parental involvement, bad news about the drug comes out of India.

Thaindian News reports:

“A vascular disease called deep vein thrombosis (DVT) is on the rise and doctors say it has a lot to do with the increase in sales of over-the-counter contraceptive pills.

“The percentage of DVT in women has seen an increase and frequencies of the disease are found in women taking birth control pills or contraceptives without any prescription,” said Rajiv Parakh, chairman of the division of peripheral vascular and endovascular sciences at Medanta hospital.

The number of cases of DVT among young women suddenly increased at the same time that the morning-after pill has been aggressively advertised. Sales of the drug increased 250 percent in one year in India, with nearly 8.2 million of the pills sold in 2009.

DVT is a blood clot in a deep vein. Blood clots are a known complication of birth control pills. The morning-after pill is a high dose of birth control pills.

“Any amount of estrogen that is not required by the female body is harmful for her. The pills tend to increase the hormone level, resulting in pain and swelling caused by blood clot formation in the veins,” Nutan Agrawal, professor of gynecology at the All India Institute of Medical Sciences told Thaindian News.

As expected, teens choose the over-the-counter drug as their birth control method of choice because it’s easy to get. “Because of the availability of drugs with retailers, these contraceptives have become the quick fix to abortions in a very short span of time,” Agrawal said.

Here in the U.S., Teva, the company that owns the morning-after pill Plan B, has asked the FDA to approve its drug for over-the-counter use for anyone. Currently, anyone under 17 needs a prescription to buy it.

When I originally testified against over-the-counter access to Plan B, I pointed out the possible medical risks — including blood clots. Officials ignored the risks to women, apparently rationalizing that the low-dose birth control pills can also cause blood clots.

What they conveniently overlooked is that birth control pills require a prescription. Doctors can warn women of the risks, and of what will increase their risks (like smoking), before giving a prescription. The patients will also have someone to call — the prescribing doctor — if they suspect complications. With over-the-counter access, women mistakenly believe the drug is completely safe and needs no medical consultation.

The FDA and abortion groups — the loudest backers of the morning-after pill — act as if access to birth control is a higher priority than medical risks to women. But they’ve got it easy. They are not held responsible when women end up in the hospital.

_________________________________________________________________

Contraceptive pills a risk for women’s hearts
Wednesday, March 09, 2011 12:02:49 AM by IANS ( Leave a comment )

New Delhi, March 9 (IANS) Before you pop an emergency birth control pill, think again. Contraceptive medication might be a quick way to prevent pregnancy, but it increases the risk of heart disease among women, say experts.

A vascular disease called deep vein thrombosis (DVT) is on the rise and doctors say it has a lot to do with the increase in sales of over-the-counter contraceptive pills.

“Due to changing lifestyles, it has been seen that over-the-counter contraceptive pills can lead to DVT. The chances of DVT multiply for women who smoke and drink,” said Rajiv Parakh, chairman of the division of peripheral vascular and endovascular sciences at Medanta hospital.

“DVT is a serious vascular disease where the blood clot is formed in the deep veins that are the blood carriers, usually in the leg,” added Parakh.

With aggressive advertising of over-the-counter contraceptive pills, cases of DVT have also seen a noticeable rise in recent times, believe experts.

“The percentage of DVT in women has seen an increase and frequencies of the disease are found in women taking birth control pills or contraceptives without any prescription,” points out Parakh.

According to statistics by the government, the sale of nearly 8.2 million over-the-counter emergency contraceptive pills was reported in 2009, a 250 percent increase over 2008. The pills claim to prevent pregnancy when taken within 72 hours of having unprotected sex.

But experts explain how the estrogen content in pills, produced naturally in a woman’s body, becomes the reason for DVT occurrence.

“Any amount of estrogen that is not required by the female body is harmful for her. The pills tend to increase the hormone level, resulting in pain and swelling caused by blood clot formation in the veins,” explained Nutan Agrawal, professor of gynaecology at the All India Institute of Medical Sciences (AIIMS).

Gyneacology experts believe it is not just over- the-counter contraceptives that have caused a spurt in DVT cases but also the sedentary lifestyle.

“Sedentary lifestyle and changing work culture are some other reasons behind DVT. Sitting for long hours, erratic work hours, no exercise, smoking and junk food make up for some of the causes that have caused a shift in the hormonal imbalance,” Agrawal said.

According to the World Health Organisation (WHO), over seven percent of adolescent girls smoke cigarettes as opposed to 12 percent of adolescent boys.

“The reason that the problem of DVT and contraceptives is serious is that we are seeing a lot of young girls in their 20s coming up with cases of the disease,” points out Parakh, who said he gets over 15 cases of DVT in a month.

Agrawal cautioned on how over-the-counter contraceptive drugs have dominated birth control measures for the teen population: “Because of the availability of drugs with retailers, these contraceptives have become the quick fix to abortions in a very short span of time. There is certainly a need for awareness among young girls about sexual health.”

DVT is diagnosed through a host of symptoms that includes pain in the chest, swelling and pain in muscles and legs, and pulmonary or heart-related complications.

(Madhulika Sonkar can be contacted at madhulika.s@ians.in)

More at : Contraceptive pills a risk for women’s hearts http://www.thaindian.com/newsportal/health1/contraceptive-pills-a-risk-for-womens-hearts_100511734.html#ixzz1IJ65ZF5r

Contraceptive Dangers Rising Concern Over Side Effects

Posted in Abortion pill, birth control, Birth Control Dangers with tags , , , , , , , , , , , , , , , , on September 15, 2010 by saynsumthn

Note- This came out in 2005- research has been done to prove further dangers since:

WASHINGTON, D.C., JAN. 8, 2005 (Zenit.org).- Even as governments and family planning groups continue to push contraceptives, new evidence is coming forward on their dangerous side effects. In England, the minister for children, Margaret Hodge, declared that she was in favor of injectable contraceptives for schoolgirls, BBC reported Nov. 16.

“What is really interesting is this contraceptive injection,” she declared. “If people are having sex, you don’t want them to have babies at that age.”

Hodge’s enthusiasm for contraceptives flies in the face of scientific warnings. On Aug. 23 Reuters reported on research by a team from the University of North Carolina and Johns Hopkins University in Baltimore. Women who use the injected contraceptive Depo-Provera have a higher rate of sexually transmitted diseases, they concluded.

Charles Morrison, of Family Health International, said that more study is needed, but it is possible that Depo-Provera itself causes a susceptibility to sexually transmitted diseases. “We did adjust for differences in condom use, differences in multiple partners, differences in the number of sexual coital acts,” he told Reuters.

Depo-Provera is also under scrutiny by the U.S. Food and Drug Administration. The agency has now stipulated that the drug must carry a special warning that prolonged use can cause significant loss of bone density, the Associated Press reported Nov. 17.

Shortly after the FDA announcement, another study confirmed the problem of bone loss due to Depo-Provera, Reuters reported Dec. 23. Researchers from the University of Iowa compared 178 women using the injectable with 145 women not using hormonal contraception.

Average bone density at the hip fell 2.8% one year after starting Depo-Provera and 5.8% after two years. Loss of bone density in the spine was similar. This compares to average bone loss of less than 0.9% among the control group.

Deadly side effects

Another contraceptive with troubling consequences is the so-called patch. Last April 4 the New York Post reported on the case of 18-year-old Zakiya Kennedy, who died as a result of blood clots, formed as a result of her patch contraceptive. She had switched from using birth-control pills to the patch about three weeks before her death.

The newspaper followed this up with a Sept. 19 report tying the Ortho Evra patch, the only kind marketed in the United States, to the deaths of at least 17 women in the past two years. The article added that scores of other women using the patch have suffered complications, including 21 “life-threatening” cases of blood clots and other ailments. The data came from FDA reports obtained by the newspaper.

The article added that the manufacturer claims the patch has been used by 4 million American women since it went on sale in 2002. A company spokesman commented that the illnesses and deaths are “consistent with the health risks” of the pill, which it says kills 0.3 to 1.9 women in every 100,000 users ages 15 to 29.

Concerns over the health risks of another contraceptive forced the FDA to step in a few days ago to correct a TV commercial. Reuters reported Dec. 30 that the FDA warned Barr Pharmaceuticals that its ads for Seasonale pills failed to mention the side effect of frequent and substantial bleeding.

The FDA warned the company that the commercial misleads consumers by excluding this information, to make the birth control pill seem safer. The warning came in a letter to the company released by the FDA on Dec. 29. In addition to the bleeding problems the pill’s label warns that other side effects can include blood clots, heart attack and stroke. But the commercials, observed the FDA, use “compelling visuals” and “fast-paced scene changes” along with other techniques that distract from warning information.

Good news proved false

One recent report at first seemed to disprove health worries over contraceptives. The British newspaper Guardian on Oct. 26 noted that some studies had concluded that the pill could help protect women from heart disease and strokes. Plus, another study of women in America concluded that the pill did not increase the risk of breast or cervical cancer.

These results were presented at the American Society of Reproductive Medicine conference in Philadelphia last October. The data came from the ongoing Women’s Health Initiative (WHI) study, which is tracking a group of more than 160,000 women.

The report in the Guardian was skeptical about the positive news. It noted that the WHI study had previously reported data linking hormone replacement treatment to an increased risk of breast cancer, heart disease and strokes. The contraceptive pill and HRT are practically the same, the article noted.

The doubts proved to be prescient. On Nov. 27 the London-based Times reported that the WHI had subsequently rejected the findings drawn from its data and demanded a retraction.

Jacques Rossouw, acting director of the WHI, admitted to the Times that the study lacked credibility. “The researchers just looked at base-line data, which is very poor data,” he said. “That is why the findings are so bizarre. These kinds of results are just not credible.”

The Times followed this story up with another article, on Dec. 13, that warned of higher stroke risks for women who take the pill. Based on a study of more than 5,000 people, researchers from Canada, the United State and Spain have concluded that migraine sufferers who take the pill are up to eight times more likely to suffer a stroke than those not using it. The Times added that migraines affect an estimated 6 million people in Britain, with women being more susceptible to the problem.

So-called morning-after pills are also associated with health problems. A July 30 report by Medical News Today summarized the findings of a study published by Dr. Gene Rudd in the September issue of the Annals of Pharmacotherapy.

Last July 22, Barr Laboratories reapplied to the U.S. Food and Drug Administration to receive approval for Plan B to be made available over-the-counter, after the FDA’s initial refusal. Rudd’s article contains data arguing that easing access to Plan B would place the health of many women at risk.

Rudd noted that nonprescription access to Plan B would keep many women out of doctors’ offices and away from appropriate, comprehensive care. Additionally, Plan B may encourage more risk-taking behaviors such as “unprotected” sex that increase the spread of sexually transmitted diseases.

Health concerns are not limited to contraceptives. The abortion pill RU-486 has been linked to a number of deaths. A well-known case is the 2003 death of Holly Patterson, an 18-year-old Californian who succumbed to septic shock after taking RU-486.

Holly’s father, Monty Patterson, said that the FDA should ban the abortion pill after a third death was being linked to its use, the Associated Press reported Nov. 16. That same day, the New York Times reported that the FDA has asked that the warning label on the RU-486 be strengthened.

In an opinion article published Nov. 19 in the New York Times, Donna Harrison, an obstetrician-gynecologist and member of the American Association of Pro-Life Obstetricians and Gynecologists, accused authorities of having given the green light to the abortion pill in 2000 due to political interference by the Clinton administration.

She explained that documents recently obtained through the Freedom of Information Act reveal that the Clinton administration “pushed to get RU-486 approved before the 2000 election despite the lack of reliable data demonstrating its safety.” That news may have come too late for at least a few RU-486 users.

Dying for birth control?

Posted in Abortion, Abortion death, Abortion injury, Abortion pill, birth control, Birth Control Dangers with tags , , , , , , , , , , , , , , , , , , , on August 24, 2010 by saynsumthn

Birth Control Death
Aired: 2/17/2010 10:13PM CST

Vodpod videos no longer available.

Birth Control Death, posted with vodpod

Symptoms

Symptoms of gallbladder problems could include:

* Pain or discomfort in the upper right side of the abdomen
* Nausea
* Diarrhea
* Abdominal Bloating
* Jaundice

Symptoms of blood clots could include:

* sudden severe headaches
* unusual swelling or pain in the legs or arms
* sharp or crushing chest pain or coughing blood
* eye problems such as blurred or double vision or complete loss of vision
* pain in the back of the lower leg

YAZ/Yasmin

NPR: With Birth Control Pills, New Isn’t Always Better
by Richard Knox
Bayer HealthCare, the leading maker of birth control pills, is coming out with a brand new pill.

Natazia, as it’s called, contains a form of estrogen that’s never been used in an oral contraceptive. It also has a novel dosing regimen. Women on Natazia will take four different combinations and doses of hormones or sugar pills each month.

The new launch coincides with growing problems for Bayer’s last new contraceptive, Yaz.

Beyond Birth Control

After Yaz came out in 2006, it quickly became America’s No. 1 birth control pill, bringing Bayer $800 million last year. But now thousands of women are suing Bayer because they say Yaz caused them serious harm. Sales have dropped 15 percent in the past year.

It’s a good time to look at the Yaz saga and see if it has anything to teach women and their doctors when they choose a contraceptive.

Yaz was something entirely new in the long history of birth control pills — and not just in its chemical formulation. It was the first pill to be marketed for multiple purposes. Bayer promoted it heavily as going “beyond birth control.”

A centerpiece TV ad noted that “all birth control pills are 99 percent effective and can give you shorter, lighter periods. But there’s one pill that goes beyond the rest. It’s Yaz.”

On the screen, brightly colored balloons floated upward. Each balloon had a label — moodiness, irritability, feeling anxious, increased appetite, bloating, fatigue, headaches, muscle aches, acne. In the background, The Veronicas sang “Goodbye to You.”

A Cautionary Tale
Those ads caught the attention of a 16-year-old in Maryland named Katie Anderson.

“I do remember going to the gynecologist and asking for Yaz because I had seen the commercials,” says Anderson, who’s now 19. “That was the one I wanted.”
Anderson hoped Yaz would even out her irregular periods. She liked the implication that Yaz could treat premenstrual syndrome. And, of course, the idea of clear skin appealed to her, too.

“What girl would not fall for something that says, you know, it’s going to help with moderate or mild acne?” she says. “That’s great! That’s just a perk, that’s a plus.”
So she got her doctor to write a prescription for Yaz. It’s a choice she’d live to regret.

Misleading Ads
We’ll come back to Katie Anderson’s story. But first, let’s hear from professor Ruth Day of Duke University. She advises the Food and Drug Administration on “medical cognition” — people’s comprehension and use of medical information in advertising and drug labels.

Day says she’d never seen a campaign that made such sweeping claims as those Yaz ads. She showed the “balloon” ad to dozens of young women and asked what they thought.

“Most people thought it was going to prevent all those symptoms, period,” Days says.

For instance, 97 percent thought Yaz can treat ordinary PMS.

“It does not,” Day says, noting that the FDA approved Yaz for treating a more serious and less common condition called PMDD — premenstrual dysphoric disorder.
What girl wouldn’t fall for something that says it’s going to help with acne? That’s great. That’s a perk, a plus!

– Katie Anderson
Day also asked her research subjects if they thought Yaz treats mild acne. “Sixty-four percent said, ‘Yes, it does.’ But the truth is, it does not treat mild acne,” she says. “So people were getting this idea that Yaz ‘goes beyond.’ But they were getting the wrong message.”

The FDA agreed. Officials declared the ads misleading and ordered Bayer to run a corrective commercial. But Day found the corrective ad still left a lot of misconceptions about what Yaz can and can’t do.

But there’s no question Bayer’s aggressive ad campaign worked. Yaz catapulted past all other birth control pills — and became Bayer’s top-selling drug.

So one lesson from the Yaz saga is: Be wary of claims that a potent pill will solve all your problems — it’s probably not true. And as Day’s research has found out, all those claimed benefits tend to cloud people’s appreciation of the potential risks.

Consider The Risks
Katie Anderson learned that the hard way. She began having persistent leg pains within a month of starting on Yaz.

“I started developing this kind of pinching, twinging, numbing kind of feeling in my left butt cheek,” she recalls. She thought it was a pinched nerve.
Then a couple of weeks later, she was awakened with terrible chest pain.

“She tells me she woke up about 5 o’clock in the morning,” says Beth Anderson, Katie’s mom. “She sat bolt upright in bed — couldn’t move, couldn’t talk, was trying to cry as silently as possible because it hurt to breathe.”

When she didn’t leave for school on time, Beth went to check on her. “I found her sitting in a puddle of tears saying, ‘Mommy, I can’t breathe! Mommy, I can’t breathe! I couldn’t even reach my cell phone!’ ”

Her doctor diagnosed pleurisy, an inflammation of the chest lining that isn’t serious, and prescribed Motrin. That helped for a while, but over the next few days, Katie developed shortness of breath. And her left leg went totally numb and cold.

“My left leg was completely purple,” she says.

It turns out an enormous blood clot had formed in her leg. A piece of it had broken off and lodged in her lung. Doctors call that a pulmonary embolism, and it can be deadly.

At the emergency room, Beth recalls, “the doctor came in and he took one look at Katie’s cold, blue leg, and he said, ‘Wow! That’s a big blood clot! You’re on birth control, aren’t you?’ “

The link between birth control pills and blood clots isn’t new. It’s been known for decades. Every year a few thousand U.S. women suffer clots because they’re on the pill.
It’s possible that Yaz and Yasmin, a similar pill, carry a higher than usual risk of clotting.

Newest Pills Not Necessarily Safest

Danish researchers decided to compare the experience of millions of women taking different contraceptives. “Denmark is the only country in the world with national registration of all women with thrombotic events [blood clots], whether in public or private hospitals,” says Ojvind Lidegaard of Copenhagen University. “We also have a detailed record of women’s medication history.”

Lidegaard’s group found that women taking Yaz or Yasmin had a 64 percent higher risk of blood clots than women taking pills that have been around for decades. Their study was published late last year in the British Medical Journal.

A 64 percent higher risk is not dramatic. But it’s worrisome, given the fact that millions of women are taking the pills.

“The safest is still, surprisingly, one of the oldest pills,” says Dr. Frits Rosendaal, an expert in clotting disorders at Leiden University in Holland.

Rosendaal led another study that also found that women taking Yaz have a higher risk of clotting than those on older birth control pills — about twice as high. That paper also appeared in the British Medical Journal.

“There are convincing indications this pill is less safe than other pills,” Rosendaal says, adding that there’s really no difference in Yaz’s effect on other menstrual symptoms.

Bayer strongly disagrees. The company wouldn’t make a spokesman available to talk about these issues. In a statement, it said that studies the company funded show its pills are no riskier than other contraceptives.

For its part, the FDA looked at all the studies. It found flaws in the Danish and Dutch results. The agency has commissioned its own study, due out sometime next year. The leader of that study, Dr. Stephen Sidney of Kaiser Permanente Health Care, says his reading of the data so far is that “it’s a bit of a mix,” and that the relative risk of Yaz and Yasmin “is an open question.”

Some Women At Higher Risk

On one point, there’s no controversy. Some women have a much higher risk of clotting and death when they take birth control pills. And most of them don’t know they’re at risk.

Katie Anderson was one of these. She has a “superclotting” gene called Factor V Leiden. In fact, Rosendaal’s group in Leiden discovered it.

The gene makes her 35 times more likely to develop a blood clot when she takes any oral contraceptive. With Yaz, her odds might have been even higher.

Factor V Leiden isn’t rare. Rosendaal says about 1 in 5 Caucasians has it, but it’s not routinely tested for. It turns out Katie’s father has the gene. Beth Anderson says she pointed that out to Katie’s doctor before she went on birth control pills.

“I wanted to make sure that wasn’t going to be an issue,” Beth Anderson says. The doctor, she reports, “said she was not aware there was any specific problem with that.”

The leaflets inside all packets of birth control pills warn women not to take them if they have a family history of clotting. But that’s often not mentioned in TV ads. The ads for Yaz simply warned that women over 35 shouldn’t smoke because that increases the risk of blood clots.

“Both Katie and I assumed that since she was well under 35, she wasn’t overweight, and she had never smoked, that it would be safe,” Beth says. “We assumed wrong.”
Katie is now one of 2,700 or so women suing Bayer over Yaz. Three years later, she’s left with a massive clot in her leg that requires her to wear a compression stocking to prevent swelling. She can’t do many of the things she loved to do, and can’t be on her feet for long. The clot may never go away.

“I have to be patient with myself,” she says. “Maybe I can’t run and I can’t hike for very long, but at least I have my legs. At least I can walk.”
So another lesson is: Women and girls thinking of taking the pill should pay attention to the fine print. Their parents, too, if they’re in the picture. And especially their doctors.

As Katie Anderson puts it: “I want people to understand it’s not just a little pill. I want people to understand the risks, understand what the symptoms of a blood clot are like, and really to take it seriously.”

New Pill On Market
So now, Bayer’s introducing another birth control pill.

This happens over and over again. It’s the way the pharmaceutical business works, especially when there’s an enormous market like the one for birth control pills. (About 13 million American women take them, and 100 million around the world.) To garner market share, companies regularly come up with new formulations and market them as new and improved.

The pressure’s even greater when lawsuits have dimmed the luster of a previous drug, or when a company faces competition from generic versions, as is now true of Yaz.
Dr. Edio Zampaglione, senior director of medical affairs for women’s health care at Bayer, and the official in charge of the company’s latest new pill, says its launch has nothing to do with these economic factors. He says Bayer developed Natazia because women need more contraceptive options.

“Each woman is different, and each woman will feel differently on these different types of hormones and will react differently to them,” Zampaglione says.

To some, that might be an argument for caution. When a new birth control pill comes out, no one really knows how millions of women will react to it. Pre-market studies of Natazia involved only about 3,000 women. The unknowns are even greater when a contraceptive contains hormones and combinations never used before.
Beth Anderson says Katie’s story contains a final lesson for women tempted to take the new pill.

“Really, the moral of the story is that you shouldn’t use the latest and greatest drugs unless there’s some reason that the ones that have been around don’t work for you,” she says.

That’s the philosophy of Rosendaal, the Dutch clotting expert.

“Personally, I would not start using a new drug unless it’s proven to be better,” Rosendaal says. “Because we know that all drugs have side effects, and we also know that for newer ones which have not yet been used by millions of people, the side effects are generally unknown.”

Bayer is monitoring how its new pill is doing in up to 70,000 women. But results of those studies won’t be available for at least five years.

ABC News- Birth Control and Blood Clots (Video here )

READ: After 2 More Deaths, Planned Parenthood Alters Method for Abortion Pill

FDA Says 2 More Women Have Died After Taking Abortion Pill
Agency Is Investigating; 7 Fatalities Now Tied to RU-486

By Marc Kaufman
Washington Post Staff Writer
Saturday, March 18, 2006

The Food and Drug Administration reported yesterday that two more women have died after taking the RU-486 abortion pill, bringing to seven the number of fatalities associated with the drug since it was approved for use in 2000.

The agency said that it was investigating the new reports, provided by the manufacturer of the drug, but so far was not able to confirm any cause of death. In four earlier fatalities of California women who had undergone medical abortions, the victims died of a form of blood poisoning caused by Clostridium sordellii , a common but rarely fatal bacterium.

Opponents of abortion quickly described the FDA advisory as another reason to ban the abortion pill, sold as Mifeprex.

“RU-486 is a deadly drug that is killing pregnant women,” Sen. Jim DeMint (R-S.C.), who has co-sponsored a bill to take the drug off the market pending a review, said in a statement. “This drug should never have been approved, and it must be suspended immediately.”

But supporters said that the pill, which has been used worldwide for years, remains safe.

“To put this in context . . . 560,000 medication abortions have occurred in the United States. We know of seven reported deaths of women who had medication abortions in North America,” Vanessa Cullins, vice president for medical affairs of the Planned Parenthood Federation of America, said in a statement. “At this time, none of those deaths have been directly attributed” to the abortion pill, she said.

Though commonly known as RU-486, this medical abortion actually entails taking two pills. The first, an antiprogestin, binds itself to the wall of the uterus, triggering the shedding of the uterine wall and not allowing the embryo to become implanted. One or two days later, the woman takes another drug — misoprostol — that causes her cervix to soften and dilate so the embryo can be expelled.

As a precaution, Cullins said, Planned Parenthood is changing its policy on how medical abortions should be administered. In the past, many women received misoprostol vaginally, although the FDA had never reviewed or approved that method. Vaginal use is considered to be more effective and has fewer side effects, but Cullins said that her organization would no longer recommend that method.

In its advisory, the FDA pointedly said that the safety and effectiveness of vaginal use of the second drug “has not been established.” It also said that providers of medical abortion and emergency-room staffs should investigate the possibility of blood poisoning whenever women who have taken the drugs come in complaining of nausea, vomiting or weakness unassociated with fever or other signs of infection.

The FDA said yesterday that it did not know whether the clostridium bacteria played any role in the most recent deaths, but the agency did establish that it was present in four earlier fatalities. One other death related to medical abortion was in a woman who had an ectopic pregnancy — a condition where RU-486 is not considered appropriate.

The issue of clostridium infection will be discussed at a public workshop in May hosted by the FDA and the Centers for Disease Control and Prevention. The bacterium has been associated with a small number of deaths and more hospitalizations involving both medical abortions and skin grafts.

The agency’s handling of the seven deaths of women who had undergone medical abortion was criticized by opponents of the drug.

“The FDA has pulled other drugs that have caused fewer deaths and less severe complications than RU-486,” Wendy Wright, president of Concerned Women for America, said in a statement. “Why the double-standard for an abortion drug that is now linked to the deaths of seven healthy women and over 800 other reported complications?”

Opponents of medical abortion filed a citizen’s petition with the FDA soon after the drug was approved for use, but the FDA has never acted on it. In addition, Rep. Roscoe G. Bartlett (R-Md.) introduced a bill in 2003 — called Holly’s Law, after Holly Patterson, an 18-year-old California woman who died following a medical abortion — that would ban use of RU-486. The bill has 79 co-sponsors.

Bartlett said yesterday that the maker of Mifeprex, Danco Laboratories LLC, should pull the drug from the market. If it refuses, he said, the FDA should force its withdrawal.

Lawsuit filed in abortion clinic death

Posted in Abortion, abortion clinic safety, Abortion complication, Abortion death, Abortion injury, Abortionist, Andrew Rutland with tags , , , , , , , , , , on August 16, 2010 by saynsumthn


Family sues doctor in abortion death
Aug. 16, 2010 By COURTNEY PERKES
THE ORANGE COUNTY REGISTER

The family of an abortion patient whose death was recently reclassified as a homicide has filed a malpractice lawsuit against Dr. Andrew Rutland.

Rutland, an Anaheim Hills obstetrician/gynecologist, faces discipline by the California Medical Board in the death of Ying Chen, 30. She sought an abortion at a San Gabriel strip mall clinic in July 2009, but suffered a heart attack and died from a fatal reaction to local anesthesia.

The suit, filed last month in Los Angeles Superior Court, was brought by Chen’s boyfriend, Zixiang Hu, on behalf of their 2-year-old daughter. It alleges that the clinic, which was also used for acupuncture, was not properly equipped to perform an abortion and that Rutland failed to adequately attempt to revive her.

“This is a doctor who performed a procedure he should not have been performing in those conditions,” said attorney Jeffrey Bell, who is representing the family. “He started a procedure, that if there were any complications, they weren’t prepared for it.”

Rutland has denied wrongdoing and called her death an “unpreventable complication to a local anesthetic” in a July 15 letter.

Chen’s death was originally ruled accidental, but the Los Angeles County coroner’s department changed the cause to homicide after receiving more information from medical board investigators. No criminal charges have been filed and the case is still under review, a spokeswoman for the Los Angeles County district attorney’s office said Monday.

A June report from the chief medical examiner described the circumstances leading to Chen’s death as “gross and wanton disregard for the well being of the patient.

Dr. Lakshmanan Sathyavagiswaran wrote that in a hospital setting with a trained anesthesiologist, “the outcome would have been different and the patient would have survived.”

He noted that the clinic, which was not licensed to perform abortions, was a “dangerous environment for any potential resuscitation.” He cited expired drugs, lack of oxygen and dangerous drugs stored in mislabeled drawers. Sathyavagiswaran said that in his opinion, “the death occurred at the hands of the physician due to his action and inaction.”

Another document from an anesthesiology consultant who reviewed the case said Rutland was not attempting to resuscitate Chen until a paramedic asked him if he knew CPR.

The original medical examiner, Dr. Yulai Wang, wrote in a report that he still believes the death was accidental, although “there were serious problems regarding physician and clinic.”

Rutland’s attorney, Paul Hittlelman of Los Angeles, said there was a “lack of unanimity” in the coroner’s office but declined to comment further. He said he was not aware of the civil suit.

Rutland lost his medical license in 2002 after settling with the board on a number of allegations by admitting negligence in the death of a baby who died after a forceps delivery. He was reinstated to practice medicine in 2007.

A hearing has been set for February to determine if Rutland will lose his license again. Earlier this year, a judge barred him from performing surgical abortions or delivering babies pending the outcome.

The wrongful death lawsuit also names Dr. Lars Erik Hanson of San Gabriel, who owned the clinic and also attempted resuscitation efforts. The medical board on Thursday filed a disciplinary action against Hanson, accusing him of running an abortion clinic that was not adequately equipped or staffed.

Additionally, the board documents accuse Hanson of unprofessional conduct, alleging that after Chen suffered the reaction, Hanson fled the scene. A police officer had to return him to the clinic, where he allegedly refused to cooperate with the investigation. Hanson could not be reached for comment.